Debut Plus

Goldline Pharmaceutical Limited

Listed
SME IPO

Price Band

₹43

Lot Size

3000 shares

Min ₹1,29,000

Issue Size

₹11.61 Cr

GMP (Grey Market)

₹15 (34.9%)

AI Analysis

Sign in to get a free AI-powered analysis of this IPO — positives, concerns and the bottom line in plain language.

Issue Details
IPO Open Date12 May 2026
IPO Close Date14 May 2026
Basis of Allotment
Refunds Initiation
Listing Date19 May 2026
Face Value
Fresh Issue
Offer for Sale
Minimum Investment (Retail)₹1,29,000
RegistrarBigshare Services Pvt.Ltd.check allotment ↗
Lead ManagersCumulative Capital Pvt.Ltd.
Subscription Status

Updated 14 May 2026, 10:26 pm

QIB180.22x
NII (HNI)1,662.04x
Retail881.15x
Total840.74x
Grey Market Premium

Updated 17 Jun 2026, 1:49 pm

15

Estimated listing: 58 (34.9% over upper band)

GMP is unofficial and indicative only. It is not a reliable predictor of listing price.

Frequently asked questions — Goldline Pharmaceutical Limited IPO

What is the price band of Goldline Pharmaceutical Limited IPO?

The price band of the Goldline Pharmaceutical Limited SME IPO is ₹43 per share with a lot size of 3000 shares.

When does Goldline Pharmaceutical Limited IPO open and close?

Goldline Pharmaceutical Limited SME IPO opens on 12 May 2026 and closes on 14 May 2026.

What is the GMP of Goldline Pharmaceutical Limited IPO today?

The latest grey market premium (GMP) for Goldline Pharmaceutical Limited is ₹15 (about 34.9% over the upper price band). GMP is indicative only and not investment advice.

What is the minimum investment for Goldline Pharmaceutical Limited IPO?

The minimum investment for Goldline Pharmaceutical Limited is ₹1,29,000 (1 lot = 3000 shares).

How do I check Goldline Pharmaceutical Limited IPO allotment status?

Check your Goldline Pharmaceutical Limited allotment on the registrar (Bigshare Services) or the BSE "Status of Issue Application" page using your PAN, application number or DP/Client ID.

When will Goldline Pharmaceutical Limited IPO list?

Goldline Pharmaceutical Limited SME IPO is expected to list on 19 May 2026 on the SME exchange.

What is the issue size of Goldline Pharmaceutical Limited IPO?

The total issue size of the Goldline Pharmaceutical Limited SME IPO is ₹11.61 Cr.

Check allotment on our IPO allotment status page, or track live IPO GMP.